Pure Financial Advisors, LLC Laboratory Corp Of America Holdings Transaction History

Pure Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$209.01 - $232.56 $14,212 - $15,814	-68 Reduced 6.16%	1,036 $226,000
Q4 2023 Jan 08, 2024	BUY	$197.69 - $227.29 $218,249 - $250,928	1,104 New	1,104 $250,000
Q4 2022 Jan 09, 2023	BUY	$203.72 - $248.97 $1,833 - $2,240	9 Added 0.86%	1,051 $0
Q4 2020 Jan 12, 2021	BUY	$186.91 - $214.42 $194,760 - $223,425	1,042 New	1,042 $212,000
Q3 2020 Oct 07, 2020	SELL	$167.03 - $201.3 $206,616 - $249,008	-1,237 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$113.31 - $182.44 $140,164 - $225,678	1,237 New	1,237 $205,000
Q1 2020 Apr 07, 2020	SELL	$104.32 - $195.28 $129,043 - $241,561	-1,237 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$163.48 - $173.61 $202,224 - $214,755	1,237 New	1,237 $209,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pure Financial Advisors, LLC with notifications on news.